In vitro contracture tests in patients with various neuromuscular diseases.
In order to investigate the relationship between neuromuscular disease and malignant hyperthermia (MH) susceptibility, the caffeine and halothane in vitro contracture test (European Malignant Hyperthermia Group Protocol) were performed in 60 patients who underwent muscle biopsy for investigation of a clinically suspected neuromuscular disorder. Two test results were classified as MH susceptible, 10 as MH equivocal and 48 MH negative. The large number of equivocal results is thought to indicate the lack of specificity of the individual components of this test in patients with clinical or histological evidence of neuromuscular disease. The increased in vitro sensitivity to the drugs tested may nevertheless provide some explanation for several in vivo "MH-like reactions" reported frequently in these patients. These reactions, however, are likely to be based on pathophysiological mechanisms different from those responsible for a true MH crisis.
Heytens
L
L
Department of Intensive Care, University Hospital Antwerp, Belgium.
Martin
J J
JJ
Van de Kelft
E
E
Bossaert
L L
LL
D000293:Adolescent; D000328:Adult; D000368:Aged; D002110:Caffeine / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D004198:Disease Susceptibility; D004342:Drug Hypersensitivity / Q000503:physiopathology; D005260:Female; D006221:Halothane / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000503:physiopathology*; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects*; D009468:Neuromuscular Diseases / Q000503:physiopathology*; D012684:Sensory Thresholds / Q000502:physiology
D002110:Caffeine; D006221:Halothane